European Healthtech startup funding raised during Q2 2022.
In Q2 2022, 157 European Healthtech companies raised a combined €1.9B across 158 funding rounds, down 17.5% versus Q2 2021. France led by capital raised, and Co-Founders was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Imcheck Therapeutics | Other | Jun 2022 | €96M |
| OMass Therapeutics | Series B | Apr 2022 | €90M |
| Proximie | Series C | Jun 2022 | €77M |
| Owkin | Series B | Jun 2022 |
| Acquisition |
| Jun 2022 |
| €1.8B |
| SPT Labtech | Acquisition | Jun 2022 | €757M |
| ReViral | Acquisition | Apr 2022 | €483M |
| Normax | IPO | Jun 2022 | €300M |
| PlusDental | Acquisition | May 2022 | €131M |
| Champion Health | Acquisition | May 2022 | €12M |
| €74M |
| Diabeloop | Other | Jun 2022 | €70M |
| Immunos Therapeutics | Series B | Jun 2022 | €68M |
| Tubulis Technologies | Series B | May 2022 | €60M |
| Sidekick Health | Series B | May 2022 | €52M |
| Humble | Other | Apr 2022 | €51M |
| Minoryx Therapeutics | Series C | May 2022 | €51M |
| Avi Medical | Series B | Apr 2022 | €50M |
| Cinclus Pharma | Other | May 2022 | €48M |
| Transition Bio | Series A | Jun 2022 | €47M |
| Cimeio Therapeutics | Series A | Apr 2022 | €46M |
| CARMAT | Other | Apr 2022 | €41M |
